EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RIG-I Stimulation Enhances the Effector Function and Proliferation of Primary Human CD8+ T Cells

Adham Abuelola Mohamed iD, Christina Wallerath iD, Charlotte Hunkler, Gunther Hartmann, Sanda Stankovic, Andrew G Brooks, Martin Schlee

International Journal of Molecular Sciences · 27.03.2026 · 27 (7) · 3058

DOI: 10.3390/ijms27073058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2026. Verfasst von Adham Abuelola Mohamed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: DEAD Box Protein 58, CD8-Positive T-Lymphocytes, Influenza, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG, EXC2151, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytotoxic CD8 T lymphocytes are crucial in antiviral immune responses. However, their recruitment to infection sites renders them at risk of viral infection, which could affect their effector activity. CD8 T lymphocytes express RIG-I, which detects cytosolic viral RNA and subsequently induces antiviral gene expression. We investigated how Influenza A virus infection and synthetic triphosphorylated double-stranded RNA, a specific RIG-I ligand, influence TCR-dependent effector responses in primary human CD8 T cells. Cells were isolated from healthy donors and either infected with the reassortant virus RG-PR8-Brazil78 (H1N1) or transfected with the synthetic RNA. Proliferation, degranulation, and cytokine production upon anti-CD3/CD28 stimulation were assessed using flow cytometry and intracellular cytokine staining. Type I IFN production and downstream signaling were measured using IFN-I reporter assay and Western blotting. CRISPR/Cas9 gene editing was employed to knock out RIG-I and STAT2 to evaluate their roles in antiviral responses. Influenza A virus infection of CD8 T cells stimulated RIG-I and activated downstream pathways, including TBK1 and NF-κB, resulting in type-I interferon secretion. Transfection of cytotoxic CD8 T lymphocytes with synthetic RIG-I ligands not only stimulated these pathways but also enhanced the proliferation of CD8 T cells in vitro and protected them from influenza A virus infection. In line with a positive effect on CD8 effector function, both influenza A virus infection and RIG-I ligand transfection enhanced CD8 T cell degranulation and cytokine secretion. Conversely, activation of CD8 T lymphocytes via CD3/CD28 crosslinking increased their susceptibility to influenza A virus infection. We demonstrated that RIG-I stimulation by virus infection or RIG-I ligand transfection promotes intrinsic antiviral pathways and enhances CD8 T-cell effector functions and proliferation. This suggests that RIG-I agonists could enhance and prolong the effector function of cytotoxic CD8 T lymphocytes in immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DEAD Box Protein 58CD8-Positive T-LymphocytesInfluenza, HumanHumansCell ProliferationReceptors, ImmunologicInfluenza A Virus, H1N1 SubtypeSignal TransductionLymphocyte ActivationCytokinesInterferon Type ICells, CulturedProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

CD8 T cellsIFN-IRIG-Iinfluenza A virusnucleic acid sensing

Substanzen

DEAD Box Protein 58RIGI protein, humanReceptors, ImmunologicCytokinesInterferon Type ITBK1 protein, humanProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany.
  • Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3010, Australia.
  • Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, University of Tübingen, 72076 Tübingen, Germany.

ORCID-Profile: Adham Abuelola Mohamed, Christina Wallerath

Förderung

  • DFG
  • EXC2151
  • National Health and Medical Research Council
  • Deutsche Forschungsgemeinschaft
  • Germany’s Excellence Strategy—EXC2151

Zitieren

APA

Mohamed, A. A., Wallerath, C., Hunkler, C., Hartmann, G., Stankovic, S., Brooks, A. G., & Schlee, M. (2026). RIG-I Stimulation Enhances the Effector Function and Proliferation of Primary Human CD8+ T Cells. International Journal of Molecular Sciences, 27(7), 3058. https://doi.org/10.3390/ijms27073058

Vancouver

Mohamed AA, Wallerath C, Hunkler C, Hartmann G, Stankovic S, Brooks AG, et al. RIG-I Stimulation Enhances the Effector Function and Proliferation of Primary Human CD8+ T Cells. International Journal of Molecular Sciences. 2026;27(7):3058. doi:10.3390/ijms27073058

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Adham Abuelola and Wallerath, Christina and Hunkler, Charlotte and Hartmann, Gunther and Stankovic, Sanda and Brooks, Andrew G and Schlee, Martin},
  title = {RIG-I Stimulation Enhances the Effector Function and Proliferation of Primary Human CD8+ T Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3058},
  doi = {10.3390/ijms27073058}
}
Kostenlos starten →